You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Non muscle invasive bladder cancer, recurrence, progression

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-Muscle Invasive Bladder Cancer, Self Efficacy, Smoking Behaviors Trial in Istanbul (Behavioral: Motivational Interviewing

Not yet recruiting
  • Non-Muscle Invasive Bladder Cancer
  • +4 more
  • Behavioral: Motivational Interviewing with WhatsApp video call
  • Istanbul, Turkey
    İrem Nur Ozdemir
Jan 20, 2023

Bladder Cancer Recurrent, Non-Invasive Bladder Urothelial Carcinoma Trial in Ankara, Istanbul, Izmir

Recruiting
  • Bladder Cancer Recurrent
  • Non-Invasive Bladder Urothelial Carcinoma
    • Ankara, Turkey
    • +2 more
    Apr 10, 2022

    Bladder Cancer Trial in Roskilde (Urine test)

    Recruiting
    • Bladder Cancer
      • Roskilde, Denmark
        Zealand University Hospital
      Oct 5, 2022

      BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder

      Recruiting
      • Bladder Cancer
        • Little Rock, Arkansas
        • +2 more
        Aug 6, 2023

        Non-muscle Invasive Bladder Cancer Trial in Chengdu (RC48-ADC)

        Not yet recruiting
        • Non-muscle Invasive Bladder Cancer
        • Chengdu, Sichuan, China
          West China Hospital
        Aug 10, 2023

        Neutrophils to Lymphocytes Ratio in Predicting Response to BCG

        Completed
        • Urinary Bladder Cancer
        • +4 more
        • Neutrophil to lymphocyte ratio
        • Cairo, Egypt
          Ain Shams university
        Jul 15, 2023

        Tool in Non-muscle Invasive Bladder Cancer (NMIBC)

        Not yet recruiting
        • Non-muscle-invasive Bladder Cancer
          • (no location specified)
          Apr 11, 2023

          Bladder Cancer Trial (Second transurehral resection of bladder tumour)

          Completed
          • Bladder Cancer
          • Second transurehral resection of bladder tumour
          • (no location specified)
          Feb 23, 2021

          Non-muscle-invasive Bladder Cancer, Non-Muscle Invasive Bladder Urothelial Carcinoma, High Risk Non-Muscle Invasive Bladder

          Not yet recruiting
          • Non-muscle-invasive Bladder Cancer
          • +2 more
          • PDD-TURBT with hexaminolevulinate (Hexvix®)
          • Power Led Saphira (TM) from KARL STORZ
          • (no location specified)
          Jul 24, 2023

          Non-muscle-invasive Bladder Cancer Trial (Cystoscopy, Bladder EpiCheck urine test, Xpert Bladder Cancer Monitor urine test)

          Not yet recruiting
          • Non-muscle-invasive Bladder Cancer
          • Cystoscopy
          • +2 more
          • (no location specified)
          Apr 4, 2023

          Non-muscle Invasive Bladder Cancer Trial (TARA-002)

          Not yet recruiting
          • Non-muscle Invasive Bladder Cancer
          • TARA-002
          • (no location specified)
          Jul 14, 2023

          High-risk Non-muscle Invasive Bladder Cancer Trial (SHR-2005)

          Not yet recruiting
          • High-risk Non-muscle Invasive Bladder Cancer
          • (no location specified)
          Oct 25, 2023

          Non-Muscle Invasive Bladder Cancer, HER2 Trial (RC48, Tislelizumab)

          Not yet recruiting
          • Non-Muscle Invasive Bladder Cancer
          • HER2
          • (no location specified)
          Jul 16, 2023

          Muscle-Invasive Bladder Carcinoma, Programmed Cell Death Protein 1 Inhibitor, Radiotherapy Trial in Guangzhou (Toripalimab,

          Not yet recruiting
          • Muscle-Invasive Bladder Carcinoma
          • +2 more
          • Guangzhou, Guangdong, China
            Cancer Center, Sun Yat-sen University
          Aug 3, 2023

          Uromonitor asBiomarker for Optimization of NMIBC Management by

          Not yet recruiting
          • Non-muscle-invasive Bladder Cancer
            • (no location specified)
            May 9, 2023

            Non-muscle-invasive Bladder Cancer Trial in Shanghai (BCG combined with Tislelizumab)

            Not yet recruiting
            • Non-muscle-invasive Bladder Cancer
            • BCG combined with Tislelizumab
            • Shanghai, Shanghai, China
              Ruijin Hospital, Shanghai Jiaotong University School of Medicine
            Oct 12, 2022

            Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8 Trial in Seattle

            Recruiting
            • Muscle Invasive Bladder Carcinoma
            • +2 more
            • Lymphadenectomy
            • +2 more
            • Seattle, Washington
              Fred Hutch/University of Washington Cancer Consortium
            Jan 9, 2023

            Non-muscle-invasive Bladder Cancer Trial in Cairo (BCG, Gemcitabine)

            Recruiting
            • Non-muscle-invasive Bladder Cancer
            • Cairo, Egypt
              Mohamed Fawzy Salman
            Nov 19, 2022

            Bladder Cancer Trial in Jinan (Pseudomonas aeruginosa)

            Recruiting
            • Bladder Cancer
            • Pseudomonas aeruginosa
            • Jinan, Shandong, China
              Qilu hospital
            Jul 26, 2023

            Non-muscle-invasive Bladder Cancer Trial in Xi'an (Standard infusion chemo, BL - 5 ala PDT)

            Not yet recruiting
            • Non-muscle-invasive Bladder Cancer
            • Standard infusion chemotherapy
            • BL - 5 ala PDT
            • Xi'an, Shaanxi, China
              Dalin He
            Sep 19, 2022

            Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive

            Recruiting
            • Non Muscle Invasive Bladder Cancer
            • N803 plus Bacillus Calmette-Guerin (BCG)
            • Honolulu, Hawaii
              Island Urology
            Aug 7, 2023

            Bladder Cancer, Bladder Cancer Recurrent, Tumor Recurrence Trial (Bacillus Calmette-Guerin: Strain Russian BCG-I, Bacillus

            Not yet recruiting
            • Bladder Cancer
            • +5 more
            • Bacillus Calmette-Guerin: Strain Russian BCG-I
            • Bacillus Calmette-Guerin: Strain TICE
            • (no location specified)
            Apr 7, 2022

            Non-Muscle- Invasive Bladder Cancer Trial (Durvalumab, BCG)

            Not yet recruiting
            • Non-Muscle- Invasive Bladder Cancer
            • Durvalumab
            • BCG
            • (no location specified)
            Jul 5, 2023

            High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma, Stage 0a Bladder Cancer AJCC v8, Stage 0is Bladder Cancer AJCC v8

            Not yet recruiting
            • High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma
            • +3 more
            • PD-L1/IDO Peptide Vaccine
            • Pembrolizumab
            • Sacramento, California
              University of California Davis Comprehensive Cancer Center
            Apr 24, 2023

            Non-Muscle Invasive Bladder Cancer Trial in Québec (Bicalutamide, Control Arm)

            Recruiting
            • Non-Muscle Invasive Bladder Cancer
            • Québec, Canada
              CHU de Québec-Université Laval
            Jul 13, 2022